Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sphenopalatine Block vs Blood Patch for Post-dural Puncture Headaches
NCT07354464Phase 3Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Feb 2026
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine 10% oropharyngeal spray in post-dural puncture headache (PDPH), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Started Feb 2026; status: recruiting.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT07354464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07354464.